[Inflammation markers in daily practice].
Cardiovascular diseases and infections remain the first mortality causes in ESRD patients. European recommendations for good clinical practice in the hemodialysis field advocate to use the inflammation markers in daily practice. These markers foretell both cardiovascular and global mortality. They also enable to detect the silent infections (parodontitis, Heliobacter pilory infection, shunt infection in PTFE), to make sure of the dialysis biocompatibility (microbiological quality of the dialysate, use of biocompatible membrane). The C-reactive protein is the most current and used marker. Its use, combined with the procalcitonin measurement, specific marker for bacterial infection, would enable the diagnostic and therapeutic strategy improvement.
Le Roy
F
F
Service de néphrologie, Centre hospitalier universitaire de Rouen. Frank.Le-Roy@chu-rouen.fr
Barbier
S
S
Passos
E Martin
EM
Godin
M
M
D015415:Biomarkers / Q000097:blood; D001799:Blood Sedimentation; D002097:C-Reactive Protein / Q000032:analysis; D002116:Calcitonin / Q000032:analysis; D015740:Calcitonin Gene-Related Peptide; D002318:Cardiovascular Diseases / Q000097:blood* / Q000401:mortality; D003663:Decision Trees; D005340:Fibrinogen / Q000032:analysis; D006023:Glycoproteins / Q000097:blood; D006801:Humans; D007249:Inflammation / Q000097:blood*; D007676:Kidney Failure, Chronic / Q000097:blood* / Q000401:mortality; D011498:Protein Precursors / Q000032:analysis; D006435:Renal Dialysis
D015415:Biomarkers; C000606589:CALCA protein, human; D006023:Glycoproteins; D011498:Protein Precursors; D005340:Fibrinogen; D002116:Calcitonin; D002097:C-Reactive Protein; D015740:Calcitonin Gene-Related Peptide